Abstract
Feline immunodeficiency virus (FIV) infection causes a widespread natural immunodeficiency syndrome in cats that is considered a suitable animal model for studying human immunodeficiency virus (HIV) infection and pathogenesis. Short term cultures of bone marrow derived feline macrophages stimulated with recombinant feline interferon-gamma (r-IFN-gamma) and lipopolysaccharide (LPS) were shown to produce nitric oxide. Feline macrophages were shown to express cannabinoid receptors, and nitric oxide production decreased after in vitro exposure to synthetic cannabinoid CP-55940. Both cannabinoid receptors, CB1 and CB2, were involved in this process, since the inhibition was reversed by selective cannabinoid antagonists for both of these receptors.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Bone Marrow Cells / immunology
-
Bone Marrow Cells / metabolism*
-
Bone Marrow Cells / pathology
-
Camphanes / pharmacology
-
Cannabinoids / immunology
-
Cannabinoids / metabolism
-
Cannabinoids / pharmacology*
-
Cats
-
Cyclohexanols / pharmacology
-
Disease Models, Animal
-
Feline Acquired Immunodeficiency Syndrome / immunology*
-
Feline Acquired Immunodeficiency Syndrome / pathology
-
Histocytochemistry
-
Immunosuppressive Agents / pharmacology
-
Macrophages / drug effects*
-
Macrophages / immunology
-
Macrophages / metabolism
-
Nitric Oxide / antagonists & inhibitors
-
Nitric Oxide / biosynthesis*
-
Phagocytosis
-
Piperidines / pharmacology
-
Pyrazoles / pharmacology
-
Receptors, Cannabinoid
-
Receptors, Drug / antagonists & inhibitors
-
Receptors, Drug / metabolism
-
Rimonabant
Substances
-
Camphanes
-
Cannabinoids
-
Cyclohexanols
-
Immunosuppressive Agents
-
Piperidines
-
Pyrazoles
-
Receptors, Cannabinoid
-
Receptors, Drug
-
SR 144528
-
Nitric Oxide
-
3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol
-
Rimonabant